Advertisement
Screener

Filana Therapeutics, Inc. (FLNA) Lessee, Operating Lease, Discount Rate

2.8 / 5 stars · 68/120 Roast Me

Filana Therapeutics, Inc. Lessee, Operating Lease, Discount Rate

Filana Therapeutics, Inc. (FLNA) had Lessee, Operating Lease, Discount Rate of 3.25% as of 2020-09-30, per its 10-K filed 2023-02-28.

Discontinued › Notes › Leases

us-gaap:LesseeOperatingLeaseDiscountRate · last filed 2023-02-28

  • 2020-09-30: Lessee, Operating Lease, Discount Rate 3.25%.
  • 2020-06-30: Lessee, Operating Lease, Discount Rate 5.50%.
  • 2020-03-31: Lessee, Operating Lease, Discount Rate 5.50%.
  • 2019-01-01: Lessee, Operating Lease, Discount Rate 5.50%.
Period endLessee, Operating Lease, Discount Rate
2020-09-303.25%
10-K · filed 2023-02-28
2020-06-305.50%
10-Q · filed 2020-08-12
2020-03-315.50%
10-Q · filed 2020-05-06
2019-01-015.50%
10-K · filed 2020-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Actinium Pharmaceuticals, Inc. (ATNM)United States$0.038B2.73
PMGC Holdings Inc. (ELAB)United States$0.037B
Celularity Inc (CELU)United States$0.038B-0.34
BriaCell Therapeutics Corp. (BCTX)$0.037B
CervoMed Inc. (CRVO)United States$0.038B-1.39
Edesa Biotech, Inc. (EDSA)Canada$0.039B
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98
Incannex Healthcare Inc. (IXHL)$0.040B-22.32